Multidisciplinary approach in cardiomyopathies: From genetics to advanced imaging.
CMR
Cardiac magnetic resonance
Cardiomyopathy
Echocardiography
Genetics
Sudden cardiac death
Journal
Heart failure reviews
ISSN: 1573-7322
Titre abrégé: Heart Fail Rev
Pays: United States
ID NLM: 9612481
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
accepted:
23
11
2023
medline:
18
3
2024
pubmed:
2
12
2023
entrez:
2
12
2023
Statut:
ppublish
Résumé
Cardiomyopathies are myocardial diseases characterized by mechanical and electrical dysfunction of the heart muscle which could lead to heart failure and life-threatening arrhythmias. Certainly, an accurate anamnesis, a meticulous physical examination, and an ECG are cornerstones in raising the diagnostic suspicion. However, cardiovascular imaging techniques are indispensable to diagnose a specific cardiomyopathy, to stratify the risk related to the disease and even to track the response to the therapy. Echocardiography is often the first exam that the patient undergoes, because of its non-invasiveness, wide availability, and cost-effectiveness. Cardiac magnetic resonance imaging allows to integrate and implement the information obtained with the echography. Furthermore, cardiomyopathies' genetic basis has been investigated over the years and the list of genetic mutations deemed potentially pathogenic is expected to grow further. The aim of this review is to show echocardiographic, cardiac magnetic resonance imaging, and genetic features of several cardiomyopathies: dilated cardiomyopathy (DMC), hypertrophic cardiomyopathy (HCM), arrhythmogenic cardiomyopathy (ACM), left ventricular noncompaction cardiomyopathy (LVNC), myocarditis, and takotsubo cardiomyopathy.
Identifiants
pubmed: 38041702
doi: 10.1007/s10741-023-10373-8
pii: 10.1007/s10741-023-10373-8
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
445-462Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, Bezzina CR, Biagini E, Blom NA, de Boer RA, De Winter T, Elliott PM, Flather M, Garcia-Pavia P, Haugaa KH, Ingles J, Jurcut RO, Klaassen S, Limongelli G, Loeys B, Mogensen J, Olivotto I, Pantazis A, Sharma S, Van Tintelen JP, Ware JS, Kaski JP, ESC Scientific Document Group (2023) 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 44(37):3503–3626
Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M, ESC Scientific Document Group (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 43(40):3997–4126
Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, Duboc D, Gimeno J, de Groote P, Imazio M, Heymans S, Klingel K, Komajda M, Limongelli G, Linhart A, Mogensen J, Moon J, Pieper PG, Seferovic PM, Schueler S, Zamorano JL, Caforio AL, Charron P (2016) Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 37(23):1850–1858
pubmed: 26792875
doi: 10.1093/eurheartj/ehv727
Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK (2016) The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol 67(25):2996–3010
pubmed: 27339497
doi: 10.1016/j.jacc.2016.03.590
Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, American Heart Association, Council on Clinical Cardiology, Heart Failure and Transplantation Committee, Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups, Council on Epidemiology and Prevention (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 113(14):1807–1816
Taylor MR, Carniel E, Mestroni L (2006) Cardiomyopathy, familial dilated. Orphanet J Rare Dis 13(1):27
doi: 10.1186/1750-1172-1-27
Mosterd A, Hoes AW (2007) Clinical epidemiology of heart failure. Heart 93(9):1137–1146
pubmed: 17699180
pmcid: 1955040
doi: 10.1136/hrt.2003.025270
Gigli M, Merlo M, Graw SL, Barbati G, Rowland TJ, Slavov DB, Stolfo D, Haywood ME, Dal Ferro M, Altinier A, Ramani F, Brun F, Cocciolo A, Puggia I, Morea G, McKenna WJ, La Rosa FG, Taylor MRG, Sinagra G, Mestroni L (2019) Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy. J Am Coll Cardiol 74(11):1480–1490
pubmed: 31514951
pmcid: 6750731
doi: 10.1016/j.jacc.2019.06.072
Caforio AL, Mahon NG, Baig MK, Tona F, Murphy RT, Elliott PM, McKenna WJ (2007) Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 115(1):76–83
pubmed: 17179019
doi: 10.1161/CIRCULATIONAHA.106.641472
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62(16):e147–239
Tayal U, Ware JS, Lakdawala NK, Heymans S, Prasad SK (2021) Understanding the genetics of adult-onset dilated cardiomyopathy: what a clinician needs to know. Eur Heart J 42(24):2384–2396
pubmed: 34153989
pmcid: 8216730
doi: 10.1093/eurheartj/ehab286
Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P, Helio T, Keren A, McKenna WJ, Monserrat L, Pankuweit S, Perrot A, Rapezzi C, Ristic A, Seggewiss H, van Langen I, Tavazzi L, European Society of Cardiology Working Group on Myocardial and Pericardial Diseases (2010) Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 31(22):2715–2726
Akhtar M, Elliott PM (2019) Risk Stratification for sudden cardiac death in non-ischaemic dilated cardiomyopathy. Curr Cardiol Rep 21(12):155
pubmed: 31768884
pmcid: 6877704
doi: 10.1007/s11886-019-1236-3
Mitropoulou P, Georgiopoulos G, Figliozzi S, Klettas D, Nicoli F, Masci PG (2020) Multi-modality imaging in dilated cardiomyopathy: with a focus on the role of cardiac magnetic resonance. Front Cardiovasc Med 7:97
pubmed: 32714942
pmcid: 7343712
doi: 10.3389/fcvm.2020.00097
Katbeh A, Van Camp G, Barbato E, Galderisi M, Trimarco B, Bartunek J, Vanderheyden M, Penicka M (2019) Cardiac resynchronization therapy optimization: a comprehensive approach. Cardiology 142(2):116–128
pubmed: 31117077
doi: 10.1159/000499192
Jenkins C, Bricknell K, Hanekom L, Marwick TH (2004) Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol 44(4):878–886
pubmed: 15312875
doi: 10.1016/j.jacc.2004.05.050
Wu VC, Takeuchi M (2017) Three-dimensional echocardiography: current status and real-life applications. Acta Cardiol Sin 33(2):107–118
pubmed: 28344414
pmcid: 5364152
Sengeløv M, Jørgensen PG, Jensen JS, Bruun NE, Olsen FJ, Fritz-Hansen T, Nochioka K, Biering-Sørensen T (2015) Global longitudinal strain is a superior predictor of all-cause mortality in heart failure with reduced ejection fraction. JACC Cardiovasc Imaging 8(12):1351–1359
pubmed: 26577264
doi: 10.1016/j.jcmg.2015.07.013
Haugaa KH, Goebel B, Dahlslett T, Meyer K, Jung C, Lauten A, Figulla HR, Poerner TC, Edvardsen T (2012) Risk assessment of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy by strain echocardiography. J Am Soc Echocardiogr 25(6):667–673
pubmed: 22421028
doi: 10.1016/j.echo.2012.02.004
Potter E, Marwick TH (2018) Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction. JACC Cardiovasc Imaging 11(2 Pt 1):260–274
pubmed: 29413646
doi: 10.1016/j.jcmg.2017.11.017
Jung IH, Park JH, Lee JA, Kim GS, Lee HY, Byun YS, Kim BO (2020) Left ventricular global longitudinal strain as a predictor for left ventricular reverse remodeling in dilated cardiomyopathy. J Cardiovasc Imaging 28(2):137–149
pubmed: 32233166
pmcid: 7114450
doi: 10.4250/jcvi.2019.0111
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, ESC Scientific Document Group (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726
Petersen SE, Khanji MY, Plein S, Lancellotti P, Bucciarelli-Ducci C (2019) European Association of Cardiovascular Imaging expert consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity. Eur Heart J Cardiovasc Imaging 20(12):1321–1331
Merlo M, Gagno G, Baritussio A, Bauce B, Biagini E, Canepa M, Cipriani A, Castelletti S, Dellegrottaglie S, Guaricci AI, Imazio M, Limongelli G, Musumeci MB, Parisi V, Pica S, Pontone G, Todiere G, Torlasco C, Basso C, Sinagra G, Filardi PP, Indolfi C, Autore C, Barison A (2023) Clinical application of CMR in cardiomyopathies: evolving concepts and techniques: a position paper of myocardial and pericardial diseases and cardiac magnetic resonance working groups of Italian society of cardiology. Heart Fail Rev 28(1):77–95
pubmed: 35536402
doi: 10.1007/s10741-022-10235-9
Markousis-Mavrogenis G, Giannakopoulou A, Belegrinos A, Pons MR, Bonou M, Vartela V, Papavasiliou A, Christidi A, Kourtidou S, Kolovou G, Bacopoulou F, Chrousos GP, Mavrogeni SI (2022) Cardiovascular magnetic resonance imaging patterns in rare cardiovascular diseases. J Clin Med 11(21):6403
pubmed: 36362632
pmcid: 9657782
doi: 10.3390/jcm11216403
Haas GJ, Zareba KM, Ni H, Bello-Pardo E, Huggins GS, Hershberger RE, Study Principal Investigator (PI) and Co-Investigators: The Ohio State University (2022) Validating an idiopathic dilated cardiomyopathy diagnosis using cardiovascular magnetic resonance: the dilated cardiomyopathy precision medicine study. Circ Heart Fail15(5):e008877
Sueyoshi E, Sakamoto I, Uetani M (2010) Contrast-enhanced myocardial inversion time at the null point for detection of left ventricular myocardial fibrosis in patients with dilated and hypertrophic cardiomyopathy: a pilot study. AJR Am J Roentgenol 194(4):W293–W298
pubmed: 20308473
doi: 10.2214/AJR.09.3414
Han Y, Peters DC, Dokhan B, Manning WJ (2009) Shorter difference between myocardium and blood optimal inversion time suggests diffuse fibrosis in dilated cardiomyopathy. J Magn Reson Imaging 30(5):967–972
pubmed: 19856417
pmcid: 2862561
doi: 10.1002/jmri.21953
Lagan J, Schmitt M, Miller CA (2018) Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases. Int J Cardiovasc Imaging 34(1):35–54
pubmed: 28130644
doi: 10.1007/s10554-017-1063-9
Leyva F, Foley PW, Chalil S, Ratib K, Smith RE, Prinzen F, Auricchio A (2011) Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson13(1):29
Barison A, Aimo A, Ortalda A, Todiere G, Grigoratos C, Passino C, Camici PG, Aquaro GD, Emdin M (2018) Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy. Int J Cardiol 250:195–200
pubmed: 29107357
doi: 10.1016/j.ijcard.2017.10.043
Rapezzi C, Arbustini E, Caforio AL, Charron P, Gimeno-Blanes J, Heliö T, Linhart A, Mogensen J, Pinto Y, Ristic A, Seggewiss H, Sinagra G, Tavazzi L, Elliott PM (2013) Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34(19):1448–1458
Turvey L, Augustine DX, Robinson S, Oxborough D, Stout M, Smith N, Harkness A, Williams L, Steeds RP, Bradlow W (2021) Transthoracic echocardiography of hypertrophic cardiomyopathy in adults: a practical guideline from the British Society of Echocardiography. Echo Res Pract 8(1):G61–G86
pubmed: 33667195
pmcid: 8243716
doi: 10.1530/ERP-20-0042
Heliö T, Elliott P, Koskenvuo JW, Gimeno JR, Tavazzi L, Tendera M, Kaski JP, Mansencal N, Bilińska Z, Carr-White G, Damy T, Frustaci A, Kindermann I, Ripoll-Vera T, Čelutkienė J, Axelsson A, Lorenzini M, Saad A, Maggioni AP, Laroche C, Caforio ALP, Charron P, EORP Cardiomyopathy Registry Investigators Group (2020) ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patients. ESC Heart Fail 7(5):3013–3021
Ho CY, Day SM, Ashley EA, Michels M, Pereira AC, Jacoby D, Cirino AL, Fox JC, Lakdawala NK, Ware JS, Caleshu CA, Helms AS, Colan SD, Girolami F, Cecchi F, Seidman CE, Sajeev G, Signorovitch J, Green EM, Olivotto I (2018) Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe). Circulation 138(14):1387–1398
pubmed: 30297972
pmcid: 6170149
doi: 10.1161/CIRCULATIONAHA.117.033200
Kim HY, Park JE, Lee SC, Jeon ES, On YK, Kim SM, Choe YH, Ki CS, Kim JW, Kim KH (2020) Genotype-related clinical characteristics and myocardial fibrosis and their association with prognosis in hypertrophic cardiomyopathy. J Clin Med 9(6):1671
pubmed: 32492895
pmcid: 7356272
doi: 10.3390/jcm9061671
Authors/Task Force members; Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35(39):2733–2779
Cardim N, Galderisi M, Edvardsen T, Plein S, Popescu BA, D’Andrea A, Bruder O, Cosyns B, Davin L, Donal E, Freitas A, Habib G, Kitsiou A, Petersen SE, Schroeder S, Lancellotti P, Camici P, Dulgheru R, Hagendorff A, Lombardi M, Muraru D, Sicari R (2015) Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging 16(3):280
pubmed: 25650407
doi: 10.1093/ehjci/jeu291
Mandeş L, Roşca M, Ciupercă D, Popescu BA (2020) The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy. J Echocardiogr 18(3):137–148
pubmed: 32301048
pmcid: 7473965
doi: 10.1007/s12574-020-00467-9
Santoro F, Mango F, Mallardi A, D’Alessandro D, Casavecchia G, Gravina M, Correale M, Brunetti ND (2023) Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy. J Clin Med 12(10):3397
pubmed: 37240503
pmcid: 10218860
doi: 10.3390/jcm12103397
Yang H, Sun JP, Lever HM, Popovic ZB, Drinko JK, Greenberg NL, Shiota T, Thomas JD, Garcia MJ (2003) Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 16(3):233–239
pubmed: 12618731
doi: 10.1067/mje.2003.60
Rowin EJ, Maron BJ, Olivotto I, Maron MS (2017) Role of exercise testing in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 10(11):1374–1386
pubmed: 29122139
doi: 10.1016/j.jcmg.2017.07.016
Nagueh SF, Phelan D, Abraham T, Armour A, Desai MY, Dragulescu A, Gilliland Y, Lester SJ, Maldonado Y, Mohiddin S, Nieman K, Sperry BW, Woo A (2022) Recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: an update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 35(6):533–569
pubmed: 35659037
doi: 10.1016/j.echo.2022.03.012
Rowin EJ, Maron BJ, Haas TS, Garberich RF, Wang W, Link MS, Maron MS (2017) Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management. J Am Coll Cardiol 69(7):761–773
pubmed: 28209216
doi: 10.1016/j.jacc.2016.11.063
Habib M, Adler A, Fardfini K, Hoss S, Hanneman K, Rowin EJ, Maron MS, Maron BJ, Rakowski H, Chan RH (2021) Progression of myocardial fibrosis in hypertrophic cardiomyopathy: a cardiac magnetic resonance study. JACC Cardiovasc Imaging 14(5):947–958
pubmed: 33248971
doi: 10.1016/j.jcmg.2020.09.037
He D, Ye M, Zhang L, Jiang B (2018) Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy. Nava Heart Lung 47(2):122–126
doi: 10.1016/j.hrtlng.2017.10.008
Mentias A, Raeisi-Giglou P, Smedira NG, Feng K, Sato K, Wazni O, Kanj M, Flamm SD, Thamilarasan M, Popovic ZB, Lever HM, Desai MY (2018) Late gadolinium enhancement in patients with hypertrophic cardiomyopathy and preserved systolic function. J Am Coll Cardiol 72(8):857–870
pubmed: 30115224
doi: 10.1016/j.jacc.2018.05.060
Basso C, Corrado D, Marcus FI (2009) A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy Lancet 373(9671):1289–1300
pubmed: 19362677
Thiene G, Nava A, Corrado D, Rossi L, Pennelli N (1988) Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318(3):129–133
pubmed: 3336399
doi: 10.1056/NEJM198801213180301
Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M (1996) Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 94(5):983–91
Groeneweg JA, Bhonsale A, James CA, te Riele AS, Dooijes D, Tichnell C, Murray B, Wiesfeld AC, Sawant AC, Kassamali B, Atsma DE, Volders PG, de Groot NM, de Boer K, Zimmerman SL, Kamel IR, van der Heijden JF, Russell SD, Jan Cramer M, Tedford RJ, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Hauer RN, Calkins H (2015) Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members. Circ Cardiovasc Genet 8(3):437–446
pubmed: 25820315
doi: 10.1161/CIRCGENETICS.114.001003
Corrado D, Basso C (2022) Arrhythmogenic left ventricular cardiomyopathy. Heart 108(9):733–743
pubmed: 34257076
doi: 10.1136/heartjnl-2020-316944
Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, Nava A, Silvestri F, Blomstrom-Lundqvist C, Wlodarska EK, Fontaine G, Camerini F (1997) Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 30(6):1512–1520
pubmed: 9362410
doi: 10.1016/S0735-1097(97)00332-X
Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 121(13):1533–1541
pubmed: 20172911
pmcid: 2860804
doi: 10.1161/CIRCULATIONAHA.108.840827
Corrado D, van Tintelen PJ, McKenna WJ, Hauer RNW, Anastastakis A, Asimaki A, Basso C, Bauce B, Brunckhorst C, Bucciarelli-Ducci C, Duru F, Elliott P, Hamilton RM, Haugaa KH, James CA, Judge D, Link MS, Marchlinski FE, Mazzanti A, Mestroni L, Pantazis A, Pelliccia A, Marra MP, Pilichou K, Platonov PGA, Protonotarios A, Rampazzo A, Saffitz JE, Saguner AM, Schmied C, Sharma S, Tandri H, Te Riele ASJM, Thiene G, Tsatsopoulou A, Zareba W, Zorzi A, Wichter T, Marcus FI, Calkins H, International Experts (2020) Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J 41(14):1414–1429
Corrado D, Perazzolo Marra M, Zorzi A, Beffagna G, Cipriani A, Lazzari M, Migliore F, Pilichou K, Rampazzo A, Rigato I, Rizzo S, Thiene G, Anastasakis A, Asimaki A, Bucciarelli-Ducci C, Haugaa KH, Marchlinski FE, Mazzanti A, McKenna WJ, Pantazis A, Pelliccia A, Schmied C, Sharma S, Wichter T, Bauce B, Basso C (2020) Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria. Int J Cardiol 319:106–114
pubmed: 32561223
doi: 10.1016/j.ijcard.2020.06.005
McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, Norman M, Baboonian C, Jeffery S, McKenna WJ (2000) Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355(9221):2119–2124
pubmed: 10902626
doi: 10.1016/S0140-6736(00)02379-5
Carvajal-Huerta L (1998) Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. J Am Acad Dermatol 39(3):418–421
pubmed: 9738775
doi: 10.1016/S0190-9622(98)70317-2
Gacita AM, McNally EM (2019) Genetic spectrum of arrhythmogenic cardiomyopathy. Circ Heart Fail 12(3):e005850
pubmed: 30871346
pmcid: 6422169
doi: 10.1161/CIRCHEARTFAILURE.119.005850
Gerull B, Brodehl A (2021) Insights into genetics and pathophysiology of arrhythmogenic cardiomyopathy. Curr Heart Fail Rep 18(6):378–390
pubmed: 34478111
pmcid: 8616880
doi: 10.1007/s11897-021-00532-z
Mazurek S, Kim GH (2017) Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy. Biochim Biophys Acta Mol Basis Dis 1863(8):2064–2069
pubmed: 28454914
doi: 10.1016/j.bbadis.2017.04.020
Austin KM, Trembley MA, Chandler SF, Sanders SP, Saffitz JE, Abrams DJ, Pu WT (2019) Molecular mechanisms of arrhythmogenic cardiomyopathy. Nat Rev Cardiol 16(9):519–537
pubmed: 31028357
pmcid: 6871180
doi: 10.1038/s41569-019-0200-7
Gandjbakhch E, Redheuil A, Pousset F, Charron P, Frank R (2018) Clinical diagnosis, imaging, and genetics of arrhythmogenic right ventricular cardiomyopathy/dysplasia: JACC state-of-the-art review. J Am Coll Cardiol 72(7):784–804
pubmed: 30092956
doi: 10.1016/j.jacc.2018.05.065
Corrado D, Basso C, Leoni L, Tokajuk B, Bauce B, Frigo G, Tarantini G, Napodano M, Turrini P, Ramondo A, Daliento L, Nava A, Buja G, Iliceto S, Thiene G (2005) Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 111(23):3042–3050
Corrado D, Basso C, Leoni L, Tokajuk B, Turrini P, Bauce B, Migliore F, Pavei A, Tarantini G, Napodano M, Ramondo A, Buja G, Iliceto S, Thiene G (2008) Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. J Am Coll Cardiol 51(7):731–739
pubmed: 18279737
doi: 10.1016/j.jacc.2007.11.027
Migliore F, Zorzi A, Silvano M, Bevilacqua M, Leoni L, Marra MP, Elmaghawry M, Brugnaro L, Dal Lin C, Bauce B, Rigato I, Tarantini G, Basso C, Buja G, Thiene G, Iliceto S, Corrado D (2013) Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Arrhythm Electrophysiol 6(1):167–176
pubmed: 23392584
doi: 10.1161/CIRCEP.111.974881
Hoogendoorn JC, Venlet J, de Riva M, Wijnmaalen AP, Piers SRD, Zeppenfeld K (2023) Unipolar voltage mapping in right ventricular cardiomyopathy: pitfalls, solutions and advantages. Europace 25(3):1035–1040
pubmed: 36639881
pmcid: 10062363
doi: 10.1093/europace/euac278
Marra MP, Leoni L, Bauce B, Corbetti F, Zorzi A, Migliore F, Silvano M, Rigato I, Tona F, Tarantini G, Cacciavillani L, Basso C, Buja G, Thiene G, Iliceto S, Corrado D (2012) Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythm Electrophysiol 5(1):91–100
pubmed: 22139887
doi: 10.1161/CIRCEP.111.964635
Perazzolo Marra M, Rizzo S, Bauce B, De Lazzari M, Pilichou K, Corrado D, Thiene G, Iliceto S, Basso C (2015) Arrhythmogenic right ventricular cardiomyopathy. Contribution of cardiac magnetic resonance imaging to the diagnosis. Herz 40(4):600–606
Towbin JA, Lorts A, Jefferies JL (2015) Left ventricular non-compaction cardiomyopathy. Lancet 386(9995):813–825
pubmed: 25865865
doi: 10.1016/S0140-6736(14)61282-4
Lee TM, Hsu DT, Kantor P, Towbin JA, Ware SM, Colan SD, Chung WK, Jefferies JL, Rossano JW, Castleberry CD, Addonizio LJ, Lal AK, Lamour JM, Miller EM, Thrush PT, Czachor JD, Razoky H, Hill A, Lipshultz SE (2017) Pediatric cardiomyopathies. Circ Res 121(7):855–873
pubmed: 28912187
pmcid: 5657298
doi: 10.1161/CIRCRESAHA.116.309386
Towbin JA, Jefferies JL (2017) Cardiomyopathies due to left ventricular noncompaction, mitochondrial and storage diseases, and inborn errors of metabolism. Circ Res 121(7):838–854
pubmed: 28912186
doi: 10.1161/CIRCRESAHA.117.310987
Hoedemaekers YM, Caliskan K, Michels M, Frohn-Mulder I, van der Smagt JJ, Phefferkorn JE, Wessels MW, ten Cate FJ, Sijbrands EJ, Dooijes D, Majoor-Krakauer DF (2010) The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet 3(3):232–239
pubmed: 20530761
doi: 10.1161/CIRCGENETICS.109.903898
Rojanasopondist P, Nesheiwat L, Piombo S, Porter GA Jr, Ren M, Phoon CKL (2022) Genetic basis of left ventricular noncompaction. Circ Genom Precis Med 15(3):e003517
pubmed: 35549379
doi: 10.1161/CIRCGEN.121.003517
Filho DCS, do Rêgo Aquino PL, de Souza Silva G, Fabro CB (2021) Left ventricular noncompaction: new insights into a poorly understood disease. Curr Cardiol Rev 17(2):209–216
Wilde AAM, Semsarian C, Márquez MF, Shamloo AS, Ackerman MJ, Ashley EA, Sternick EB, Barajas-Martinez H, Behr ER, Bezzina CR, Breckpot J, Charron P, Chockalingam P, Crotti L, Gollob MH, Lubitz S, Makita N, Ohno S, Ortiz-Genga M, Sacilotto L, Schulze-Bahr E, Shimizu W, Sotoodehnia N, Tadros R, Ware JS, Winlaw DS, Kaufman ES; Document Reviewers; Aiba T, Bollmann A, Choi JI, Dalal A, Darrieux F, Giudicessi J, Guerchicoff M, Hong K, Krahn AD, MacIntyre C, Mackall JA, Mont L, Napolitano C, Ochoa JP, Peichl P, Pereira AC, Schwartz PJ, Skinner J, Stellbrink C, Tfelt-Hansen J, Deneke T; Developed in partnership with and endorsed by the European Heart Rhythm Association (EHRA), a branch of the European Society of Cardiology (ESC), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS) (2022) European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. Europace 24(8):1307–1367
Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA (2001) Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 86(6):666–671
pubmed: 11711464
pmcid: 1730012
doi: 10.1136/heart.86.6.666
Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R (1990) Isolated noncompaction of left ventricular myocardium. A study of eight cases Circulation 82(2):507–513
pubmed: 2372897
Stöllberger C, Finsterer J, Blazek G (2002) Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 90(8):899–902
pubmed: 12372586
doi: 10.1016/S0002-9149(02)02723-6
Paterick TE, Umland MM, Jan MF, Ammar KA, Kramer C, Khandheria BK, Seward JB, Tajik AJ (2012) Left ventricular noncompaction: a 25-year odyssey. J Am Soc Echocardiogr 25(4):363–375
pubmed: 22284845
doi: 10.1016/j.echo.2011.12.023
Petersen SE, Selvanayagam JB, Wiesmann F, Robson MD, Francis JM, Anderson RH, Watkins H, Neubauer S (2005) Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 46(1):101–105
pubmed: 15992642
doi: 10.1016/j.jacc.2005.03.045
Kawel N, Nacif M, Arai AE, Gomes AS, Hundley WG, Johnson WC, Prince MR, Stacey RB, Lima JA, Bluemke DA (2012) Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging 5(3):357–66. https://doi.org/10.1161/CIRCIMAGING.111.971713 . Epub 2012 Apr 12. PMID: 22499849; PMCID: PMC3399115
Jacquier A, Thuny F, Jop B, Giorgi R, Cohen F, Gaubert JY, Vidal V, Bartoli JM, Habib G, Moulin G (2010) Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J 31(9):1098–1104
pubmed: 20089517
doi: 10.1093/eurheartj/ehp595
Grigoratos C, Barison A, Ivanov A, Andreini D, Amzulescu MS, Mazurkiewicz L, De Luca A, Grzybowski J, Masci PG, Marczak M, Heitner JF, Schwitter J, Gerber BL, Emdin M, Aquaro GD (2019) Meta-analysis of the prognostic role of late gadolinium enhancement and global systolic impairment in left ventricular noncompaction. JACC Cardiovasc Imaging 12(11 Pt 1):2141–2151. https://doi.org/10.1016/j.jcmg.2018.12.029 . Epub 2019 Mar 13 PMID: 30878415
Sidhu MS, Uthamalingam S, Ahmed W, Engel LC, Vorasettakarnkij Y, Lee AM, Hoffmann U, Brady T, Abbara S, Ghoshhajra BB (2014) Defining left ventricular noncompaction using cardiac computed tomography. J Thorac Imaging 29(1):60–66
pubmed: 23689383
doi: 10.1097/RTI.0b013e31828e9b3d
Chebrolu LH, Mehta AM, Nanda NC (2017) Noncompaction cardiomyopathy: the role of advanced multimodality imaging techniques in diagnosis and assessment. Echocardiography 34(2):279–289
pubmed: 28058741
doi: 10.1111/echo.13435
Sagar S, Liu PP, Cooper LT Jr (2012) Myocarditis Lancet 379(9817):738–747
pubmed: 22185868
doi: 10.1016/S0140-6736(11)60648-X
Olejniczak M, Schwartz M, Webber E, Shaffer A, Perry TE (2020) Viral myocarditis-incidence, diagnosis and management. J Cardiothorac Vasc Anesth 34(6):1591–1601
pubmed: 32127272
doi: 10.1053/j.jvca.2019.12.052
Bracamonte-Baran W, Čiháková D (2017) Cardiac autoimmunity: myocarditis. Adv Exp Med Biol 1003:187–221
pubmed: 28667560
pmcid: 5706653
doi: 10.1007/978-3-319-57613-8_10
Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM, European Society of Cardiology Working Group on Myocardial and Pericardial Diseases (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34(33):2636–2648, 2648a-2648d
Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, Friedrich MG, Klingel K, Lehtonen J, Moslehi JJ, Pedrotti P, Rimoldi OE, Schultheiss HP, Tschöpe C, Cooper LT Jr, Camici PG (2020) Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail 13(11):e007405
pubmed: 33176455
pmcid: 7673642
doi: 10.1161/CIRCHEARTFAILURE.120.007405
Adeboye A, Alkhatib D, Butt A, Yedlapati N, Garg N (2022) A review of the role of imaging modalities in the evaluation of viral myocarditis with a special focus on COVID-19-related myocarditis. Diagnostics (Basel) 12(2):549. https://doi.org/10.3390/diagnostics12020549.PMID:35204637;PMCID:PMC8870822
doi: 10.3390/diagnostics12020549.PMID:35204637;PMCID:PMC8870822
pubmed: 35204637
Jeserich M, Konstantinides S, Pavlik G, Bode C, Geibel A (2009) Non-invasive imaging in the diagnosis of acute viral myocarditis. Clin Res Cardiol 98(12):753–63. https://doi.org/10.1007/s00392-009-0069-2 . Epub 2009 Sep 11. PMID: 19756815; PMCID: PMC2789929
Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, Kindermann I, Gutberlet M, Cooper LT, Liu P, Friedrich MG (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 72(24):3158–3176
pubmed: 30545455
doi: 10.1016/j.jacc.2018.09.072
Baggio C, Gagno G, Porcari A, Paldino A, Artico J, Castrichini M, Dal Ferro M, Bussani R, Merlo M (2021) Myocarditis: which role for genetics? Curr Cardiol Rep 23(6):58. https://doi.org/10.1007/s11886-021-01492-5.PMID:33961130;PMCID:PMC8105238
doi: 10.1007/s11886-021-01492-5.PMID:33961130;PMCID:PMC8105238
pubmed: 33961130
pmcid: 8105238
Lota AS, Hazebroek MR, Theotokis P, Wassall R, Salmi S, Halliday BP, Tayal U, Verdonschot J, Meena D, Owen R, de Marvao A, Iacob A, Yazdani M, Hammersley DJ, Jones RE, Wage R, Buchan R, Vivian F, Hafouda Y, Noseda M, Gregson J, Mittal T, Wong J, Robertus JL, Baksi AJ, Vassiliou V, Tzoulaki I, Pantazis A, Cleland JGF, Barton PJR, Cook SA, Pennell DJ, Garcia-Pavia P, Cooper LT Jr, Heymans S, Ware JS, Prasad SK (2022) Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy. Circulation 146(15):1123–1134
pubmed: 36154167
pmcid: 9555763
doi: 10.1161/CIRCULATIONAHA.121.058457
Ammirati E, Raimondi F, Piriou N, Sardo Infirri L, Mohiddin SA, Mazzanti A, Shenoy C, Cavallari UA, Imazio M, Aquaro GD, Olivotto I, Pedrotti P, Sekhri N, Van de Heyning CM, Broeckx G, Peretto G, Guttmann O, Dellegrottaglie S, Scatteia A, Gentile P, Merlo M, Goldberg RI, Reyentovich A, Sciamanna C, Klaassen S, Poller W, Trankle CR, Abbate A, Keren A, Horowitz-Cederboim S, Cadrin-Tourigny J, Tadros R, Annoni GA, Bonoldi E, Toquet C, Marteau L, Probst V, Trochu JN, Kissopoulou A, Grosu A, Kukavica D, Trancuccio A, Gil C, Tini G, Pedrazzini M, Torchio M, Sinagra G, Gimeno JR, Bernasconi D, Valsecchi MG, Klingel K, Adler ED, Camici PG, Cooper LT Jr (2022) Acute myocarditis associated with desmosomal gene variants. JACC Heart Fail 10(10):714–727
pubmed: 36175056
doi: 10.1016/j.jchf.2022.06.013
Dias A, Núñez Gil IJ, Santoro F, Madias JE, Pelliccia F, Brunetti ND, Salmoirago-Blotcher E, Sharkey SW, Eitel I, Akashi YJ, El-Battrawy I, Franco E, Akin I, Jaguszewski M, Dawson D, Figueredo VM, Napp CL, Christensen TE, Hebert K, Ben-Dor I, Ozaki Y, García-Garcia HM, Kajita AK, Akasaka T, Kurisu S, Lerman A, Waksman R. Takotsubo syndrome: state-of-the-art review by an expert panel–Part 2. Cardiovascular Revascularization Medicine 17 Nov 2018 Epub
Ieva R, Santoro F, Ferraretti A, Spennati G, De Gennaro L, Di Biase M, Brunetti ND (2013) Hyper-acute precipitating mechanism of Tako-Tsubo cardiomyopathy: in the beginning was basal hyperkinesis? Int J Cardiol 167(3):e55–e57
pubmed: 23628296
doi: 10.1016/j.ijcard.2013.03.138
Rawish E, Stiermaier T, Santoro F, Brunetti ND, Eitel I (2021) Current knowledge and future challenges in takotsubo syndrome: part 1-pathophysiology and diagnosis. J Clin Med 10(3):479
pubmed: 33525539
pmcid: 7865728
doi: 10.3390/jcm10030479
Santoro F, Stiermaier T, Tarantino N, Guastafierro F, Graf T, Moller C, Di Martino LFM, Thiele H, Di Biase M, Eitel I, Brunetti ND (2018) Impact of persistent ST elevation on outcome in patients with takotsubo syndrome. Results from the GErman Italian STress Cardiomyopathy (GEIST) registry. Int J Cardiol 255:140–144
Santoro F, Núñez Gil IJ, Stiermaier T, El-Battrawy I, Guerra F, Novo G, Guastafierro F, Tarantino N, Novo S, Mariano E, Romeo F, Romeo F, Capucci A, Bahlmann E, Zingaro M, Cannone M, Caldarola P, Marchetti MF, Montisci R, Meloni L, Thiele H, Di Biase M, Almendro-Delia M, Sionis A, Akin I, Eitel I, Brunetti ND (2019) Assessment of the German and Italian stress cardiomyopathy score for risk stratification for in-hospital complications in patients with takotsubo syndrome. JAMA Cardiol 4(9):892–899
pubmed: 31389988
pmcid: 6686773
doi: 10.1001/jamacardio.2019.2597
Santoro F, Carapelle E, Cieza Ortiz SI, Musaico F, Ferraretti A, d’Orsi G, Specchio LM, Di Biase M, Brunetti ND (2013) Potential links between neurological disease and Tako-Tsubo cardiomyopathy: a literature review. Int J Cardiol 168(2):688–691
pubmed: 23608401
doi: 10.1016/j.ijcard.2013.03.093
Santoro F, Ferraretti A, Ieva R, Musaico F, Fanelli M, Tarantino N, Scarcia M, Caldarola P, Di Biase M, Brunetti ND (2016) Renal impairment and outcome in patients with takotsubo cardiomyopathy. Am J Emerg Med 34(3):548–552
pubmed: 26806176
doi: 10.1016/j.ajem.2015.12.065
Tarantino N, Santoro F, Di Biase L et al (2020) Chromogranin-A serum levels in patients with takotsubo syndrome and ST elevation acute myocardial infarction. Int J Cardiol S0167–5273(20):33525–33527
Vriz O, Minisini R, Citro R, Guerra V, Zito C, De Luca G, Pavan D, Pirisi M, Limongelli G, Bossone E (2011) Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy. Acta Cardiol 66(6):787–790
pubmed: 22299391
doi: 10.1080/AC.66.6.2136964
Mori H, Ishikawa S, Kojima S, Hayashi J, Watanabe Y, Hoffman JI, Okino H (1993) Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli. Cardiovasc Res 27(2):192–198
pubmed: 8386061
doi: 10.1093/cvr/27.2.192
Santoro F, Costantino MD, Guastafierro F, Triggiani G, Ferraretti A, Tarantino N, Saguner A, Di Biase M, Brunetti ND (2018) Inflammatory patterns in takotsubo cardiomyopathy and acute coronary syndrome: a propensity score matched analysis. Atherosclerosis 274:157–161
pubmed: 29783063
doi: 10.1016/j.atherosclerosis.2018.05.017
Scally C, Abbas H, Ahearn T, Srinivasan J, Mezincescu A, Rudd A, Spath N, Yucel-Finn A, Yuecel R, Oldroyd K, Dospinescu C, Horgan G, Broadhurst P, Henning A, Newby DE, Semple S, Wilson HM, Dawson DK (2019) Myocardial and systemic inflammation in acute stress-induced (takotsubo) cardiomyopathy. Circulation 139(13):1581–1592
pubmed: 30586731
pmcid: 6438459
doi: 10.1161/CIRCULATIONAHA.118.037975
Zilberman L, Zalik A, Fugenfirov I, Shimoni S, George J, Goland S (2021) Residual alterations of cardiac and endothelial function in patients who recovered from takotsubo cardiomyopathy. Clin Cardiol 44(6):797–804
pubmed: 33955558
pmcid: 8207966
doi: 10.1002/clc.23604
Rivero F, Cuesta J, García-Guimaraes M, Bastante T, Alvarado T, Antuña P, Alfonso F (2017) Time-related microcirculatory dysfunction in patients with takotsubo cardiomyopathy. JAMA Cardiol 2(6):699–700
pubmed: 28273298
pmcid: 5815019
doi: 10.1001/jamacardio.2016.5993
Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C (2018) International expert consensus document on takotsubo syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 39(22):2032–2046
Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, Carbone I, Muellerleile K, Aldrovandi A, Francone M, Desch S, Gutberlet M, Strohm O, Schuler G, Schulz-Menger J, Thiele H, Friedrich MG (2011) Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA 306(3):277–286
pubmed: 21771988
doi: 10.1001/jama.2011.992